Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients

Clin Infect Dis. 2024 Oct 15;79(4):1117-1118. doi: 10.1093/cid/ciae005.

¹ Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
² Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
³ Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
⁴ Department of Medicine, VA Pittsburgh Healthcare System and University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

No abstract available

Publication types